Ticker APTX – Aptinyx – sales, description, marketcap – Tickerday.com

APTX

Aptinyx

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 155.45M; Volume: 123.15K; AvgVol 3m: 236.57K; Beta: –;

Cost estimate:

P/E: –; EPS: -1.46; EPS growth quarter/prev quarter: 24.30%;

EPS growth this year: -7.10%; EPS growth past 5 years: ;

EPS ttm: -1.46;

P/S: 53.15; P/B: 1.39; P/Cashflow: 1.47; P/FCF: ;

Sales: 3.17M; Sales growth quarter/prev quarter: -44.40%; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -46.90%; ROE – return on equity: -49.20%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 5.04%; Insider Transactions:0.00%;

Institutional Ownership: 66.80%; Institutional Transactions: 7.07%;

Data update: 07/10/2020.